What Is HPLC? Measuring Peptide Purity by Peak Area

Published October 2026 · Patriot Labs Research Team · ~18 min read

The short answer

HPLC — high-performance liquid chromatography — is an analytical method that measures a research peptide’s purity. It pushes the dissolved sample through a column packed with fine particles under high pressure, separating the peptide from its impurities in time, and reports each component as a percentage of the total peak area a detector records. When a certificate says 98% by HPLC, it means the target peptide is about 98% of the detected peak area.

The instrument does one thing supremely well: it separates. A mixture goes in as a single band; it comes out spread into a row of peaks, each a different component, each arriving at the detector at its own characteristic time. The chart of detector signal against time — the chromatogram — is the raw output, and almost everything a report says about purity is read from the sizes and positions of those peaks.^[8]

For research peptides, HPLC answers the “how much” question that identity testing cannot: not what the molecule is, but how much of the sample is that molecule rather than deletion products, truncations and other related impurities left over from synthesis. It is one of the two analyses that normally appear on a peptide’s certificate of analysis, the other being mass spectrometry for identity. The rest of this guide explains how the separation works, what the numbers mean, and what a purity figure does and does not prove.

What an HPLC actually measures

An HPLC does not measure purity directly. It measures when things come off a column and how much signal each one produces, and purity is worked out from those two facts.

The machinery is a loop. A pump drives a liquid — the mobile phase — through the system at high pressure, typically somewhere between about 50 and 1400 bar depending on the column.^[8] A small, precisely measured volume of the dissolved sample is injected into that flowing stream. The stream carries the sample onto the column, a steel tube a few centimetres long packed with microscopic particles — analytical columns are usually 2.1 to 4.6 mm across and 30 to 250 mm long.^[8] Inside the column the components separate, for reasons the next section explains, and emerge one after another into a detector, which converts each into an electrical signal plotted against time.

Two quantities come off that plot. The retention time is the horizontal position of a peak — how long that component took to pass through — and it is characteristic of a molecule under a fixed method, so a peak appearing where the target peptide is expected is one piece of evidence for its presence.^[1] The peak area is the region enclosed under a peak, and it is proportional to how much of that component reached the detector.^[8] Purity, in the end, is a statement about relative peak areas: the target peptide’s peak set against everything else that showed up.

A vocabulary grew up around these measurements, and a report may use any of it. The void time is when a completely unretained substance elutes, marking the fastest anything can travel. The retention factor (k′) expresses how much longer a component is held than that unretained marker. Selectivity (α) compares two neighbouring peaks, and resolution measures how cleanly they are separated.^[8] The International Union of Pure and Applied Chemistry fixed the meanings of these terms so that a chromatogram reads the same way in any laboratory,^[1] and pharmacopoeial system-suitability rules such as the United States Pharmacopeia’s General Chapter <621> set the thresholds a method must meet before its numbers are trusted.^[11]

Why peptides are run on reversed-phase columns

Almost all peptide purity analysis is done in one particular mode of HPLC — reversed-phase — because it separates closely related peptides better than any other common approach. The name is a historical accident, but the mechanism is straightforward.

In the earliest liquid chromatography the stationary surface was polar, such as bare silica, and the moving solvent was non-polar; this is now called normal phase. Reversed-phase flips that arrangement: the stationary surface is made non-polar and the mobile phase is water-based.^[8] The column is packed with silica particles whose surface has been coated with hydrocarbon chains — most often an eighteen-carbon chain, written C18 (also called ODS or RP-18), and sometimes a shorter C8 or C4.^[8] Those greasy chains give the particle a water-hating skin.

A peptide pushed onto such a column by a water-rich mobile phase tends to stick to that skin, held there by the same hydrophobic effect that keeps oil out of water — and the more hydrophobic the molecule, the more tightly it clings. The handbook chemistry here is well established: C18 is generally preferred for peptides and small proteins below about 5,000 daltons, with C8 giving similar but slightly different selectivity, while larger or very hydrophobic species are better suited to the shorter C4 chains.^[7] The particles are usually porous, with pore openings around 300 ångströms wide for polypeptides so that the molecules can reach the surface area inside; smaller peptides below about 2,000 in molecular weight can use 100-ångström pores.^[7] Because two peptides that differ by a single residue usually differ in hydrophobicity, reversed-phase chromatography can pull them apart — which is exactly what purity analysis needs, since the impurities in a synthetic peptide are typically near-copies of the target. The reasons those near-copies exist in the first place are covered in How Peptides Are Made.

The mobile phase: water, acetonitrile and TFA

If the column is what holds peptides back, the mobile phase is what releases them — and in reversed-phase work it is almost always a mixture of water, an organic solvent, and a small amount of an acid that tidies up the separation.

The organic solvent is the key to timing. A peptide stuck to the non-polar surface is coaxed off by raising the proportion of organic solvent, which makes the mobile phase itself less water-like and more willing to dissolve the peptide. Acetonitrile is the most commonly used modifier for peptides; methanol is an alternative.^[7] Rather than hold the mixture constant, most peptide methods use gradient elution: the run begins water-rich and the organic fraction climbs steadily, so the least hydrophobic components wash off first and the most hydrophobic last. The handbook figure for a typical peptide gradient is a slope of about 0.5 to 1% increase in organic modifier per minute, with very shallow gradients of 0.05 to 0.1% per minute used to maximise resolution, and the run usually starting at no less than 3 to 5% organic and ending at no more than 95%.^[7] A constant-composition run, by contrast, is called isocratic — a term coined by Csaba Horváth, one of HPLC’s pioneers.^[8][10]

The acid is the quiet third ingredient. Peptides carry charged groups that would otherwise interact messily with residual sites on the silica, smearing the peaks. A small amount of an ion-pairing reagent masks those charges and sharpens the separation. The most common one in peptide work is trifluoroacetic acid (TFA), normally used at about 0.1% by volume, with concentrations up to around 0.5% helping to dissolve larger or more hydrophobic species.^[7] TFA pairs with the peptide’s positive charges and lends the whole system a consistent, low-pH environment in which retention is reproducible. It is the same TFA that often ends up as the peptide’s counterion in the final powder — a separate matter, since the counterion is weighed with the peptide but is not part of it, explained in TFA vs Acetate in Peptides.

Detection: why 214 nm and 280 nm

Once components leave the column they have to be seen, and the overwhelmingly common detector for peptides is an ultraviolet absorbance monitor. Which wavelength it watches decides what it can and cannot register.

The crucial fact is that the peptide bond itself absorbs ultraviolet light. The amide linkage joining one residue to the next has an electronic transition in the far ultraviolet, roughly 190 to 220 nanometres, so a detector set near 214 nm responds to the backbone of essentially every peptide, whatever its sequence.^[16] That near-universality is why 214 nm (or the closely related 220 nm) is the default purity wavelength: a deletion impurity still has peptide bonds, so it is still counted. The handbook notes that TFA gradients can cause some baseline drift in the 210–220 nm window and advises keeping the detection wavelength as close to 215 nm as practical while trimming the TFA slightly in the stronger solvent to flatten the baseline.^[7]

Detection at 280 nm sees something different and more selective: the aromatic side chains of tryptophan and tyrosine, with a small contribution from phenylalanine, which absorb near the near-ultraviolet rather than the backbone.^[16] A peptide rich in those residues shows up strongly at 280 nm, but one without them is nearly invisible there. A diode-array detector records a whole spectrum at once, so both wavelengths — and others, such as 254 nm — can be followed from a single run, and the ratio of absorbances becomes an extra clue to a peak’s makeup.^[8] The building blocks that carry these chromophores are described in What Is an Amino Acid.

How a purity percentage is calculated

A purity figure is a ratio of areas. The detector draws a peak for each component; software integrates the area under each peak; the target peptide’s area is divided by the total area of all peaks, and the result is multiplied by a hundred. This is called area normalisation or area percent, and it is what a line reading “Purity (HPLC): 98.3%” almost always means.^[8]

The method is powerful because it needs no reference standard of the impurities: every component that absorbs at the chosen wavelength is simply counted in the total. A peptide reported at 98% by HPLC therefore has about 2% of its detected peak area coming from everything else — usually the deletion sequences, truncated chains and modified by-products that reversed-phase chromatography is so good at resolving from the main peak. Where those thresholds fall is the subject of Peptide Purity Grades Explained, which sets out what crude, desalted, and greater-than-95% or greater-than-98% material actually mean.

Three honest caveats belong with the number. First, area percent assumes every component responds about equally to the detector, which is only roughly true: an impurity that absorbs weakly at 214 nm contributes less area than its real amount, so the headline purity can read a little high. Second, the method only counts what the detector can see — a contaminant transparent at the chosen wavelength is invisible, which is one reason more than one wavelength is often recorded. Third, and most important, the percentage is a fraction of peptide-related material, not a measure of how much of the powder in the vial is peptide at all; water and counterion are weighed with the solid but never appear as peaks. That last distinction is large enough to have its own guide: What Is Net Peptide Content.

Resolution, plates and the van Deemter curve

For a purity number to mean anything, the peaks have to be sharp enough to stand apart from one another. The quality that makes them sharp is called efficiency, and understanding it explains why HPLC columns are packed with such small particles and why the newest ones run at such high pressure.

Efficiency is counted in theoretical plates — a notional number N of equilibration steps a column behaves as if it contains; the higher N, the narrower the peaks and the better two close components are resolved.^[1][8] The companion measure is plate height, H, the length of column that corresponds to one such plate, so a smaller H is better. The classic description of what controls H is the van Deemter equation, first set out by van Deemter, Zuiderweg and Klinkenberg in 1956:^[4][9]

H = A + B/u + C · u

Each term is a different way a band spreads out as it travels. The A term, eddy diffusion, comes from the many slightly different paths molecules take through the packing. The B term, longitudinal diffusion, is the band quietly spreading along the flow direction, and because it is divided by velocity it dominates when the flow is slow. The C term, resistance to mass transfer, is the lag as molecules move between the moving liquid and the stationary surface, and because it is multiplied by velocity it dominates when the flow is fast.^[9] Added together they give a curve with a minimum — an optimum velocity where the column is at its sharpest.

The route to better efficiency runs through the particles. Smaller packing particles shorten the distances in the A and C terms and flatten the curve, so the column stays efficient even at higher speed — but smaller particles also resist flow far more steeply; halving the particle diameter roughly quadruples the backpressure.^[8] For decades columns used 5-micron particles, the long-time standard.^[8] The arrival of sub-2-micron particles demanded pumps able to work far above conventional limits, and in 2004 Waters launched the first commercial ultra-high-pressure system built around them, trademarked UPLC, with the broader class now called UHPLC and running at pressures up to roughly 1200 atmospheres.^[8][12] The payoff is sharper peaks in shorter runs — the same separation, done faster and with finer resolution of the impurities that decide a purity figure.

A short history: from partition to pressure

HPLC did not appear fully formed; it is the pressurised descendant of a much older idea, and the line from that idea to a modern instrument runs through several Nobel-worthy steps.

The conceptual foundation was laid in 1941, when Archer Martin and Richard Synge described partition chromatography — separating substances by how they distribute between two liquid phases, one of them held stationary on a solid support — and used it to separate amino acids.^[2][8] The same pair introduced the theoretical-plate idea borrowed from distillation to describe column efficiency, and they received the 1952 Nobel Prize in Chemistry “for their invention of partition chromatography.”^[3] For two decades the method stayed slow, its mobile phase trickling through under gravity, with separations taking hours.^[8]

The leap to high performance came from forcing the liquid through fine packing under pressure. Csaba Horváth, who had moved to Yale’s medical school in 1964 to work on separating biological molecules that could not be vaporised, assembled a high-pressure liquid chromatograph within months and had it working by the summer of 1965.^[6][10] With Preiss and Lipsky he published the results in Analytical Chemistry in 1967, separating ribonucleosides on pellicular packings in under an hour — the first demonstration of the modern instrument.^[5][6] The theory had meanwhile been supplied in 1956 by van Deemter and colleagues, whose equation explained exactly why small particles and controlled flow would pay off.^[4] The thread from there to today is steady refinement: bonded reversed-phase silica for selectivity, ever-smaller particles for efficiency, and in 2004 the sub-2-micron, ultra-high-pressure systems that define the current state of the art.^[8][12]

Purity is not identity: HPLC and mass spectrometry together

HPLC and mass spectrometry answer two different questions, and a certificate of analysis normally carries both because neither substitutes for the other. HPLC asks how much of the sample is the main component; mass spectrometry asks what that component is.

The gap is real. A reversed-phase run can show a single, beautifully sharp peak at 99% of the total area and still not prove that the peak is the intended peptide — only that one species dominates. The measurement is about relative amount, not identity. Mass spectrometry supplies the missing half: it weighs the molecule and compares the measured mass with the mass calculated from the intended sequence, confirming the dominant peak is the right molecule and often identifying what the minor peaks are. Run together as LC-MS, the two merge into one analysis in which every chromatographic peak also gets a mass. The identity side of that pairing is the subject of What Is Mass Spectrometry.

The clean mental model is three separate facts. HPLC establishes purity — the fraction of detected material that is the target. Mass spectrometry establishes identity — that the target is the intended molecule. And amino acid analysis or nitrogen determination establishes content — how much of the weighed powder is actually peptide. No one of the three implies the others, and Understanding Peptide COA Testing shows how they sit together on a single report. For reference, Patriot Labs has every batch tested by an independent US laboratory by HPLC and mass spectrometry, and publishes the certificate of analysis on each product page — the purity figure described here is the HPLC half of that document.

What HPLC does not establish

HPLC is a purity-and-separation tool, not a verdict on everything about a sample. Several limits are worth stating plainly.

• A purity percentage is not an identity. A dominant peak is only a dominant peak; confirming it is the intended molecule needs mass spectrometry. Purity and identity are separate measurements.
• It counts only what the detector sees. A contaminant that does not absorb at the chosen wavelength, or that co-elutes exactly under the main peak, is not counted; area percent also assumes roughly equal detector response across components, which only holds approximately.
• It does not measure how much peptide is in the vial. Purity is a fraction of peptide-related material and ignores the water and counterion weighed with the powder; that is the separate question of net peptide content.
• Method conditions shape the result. Column chemistry, gradient slope, wavelength and temperature all affect which impurities resolve and how large they appear, so a purity figure is only meaningful alongside the method that produced it.
• It says nothing about biological activity or safety. A purity number describes composition, not what a compound does; this guide makes no claim about any effect of any compound in a person or an animal, and describes an analytical technique in general terms only.
• It describes the analysis, not any particular vial. What a specific batch contains is established only by that batch’s own lot-specific certificate of analysis.

Frequently asked questions

What is HPLC?

HPLC, high-performance liquid chromatography, is an analytical technique that separates the components of a liquid sample by pushing it under high pressure through a column packed with fine particles. Different components move through at different rates and leave the column at different times, where a detector records them. For research peptides it is the standard way to measure purity.

How is peptide purity measured?

Peptide purity is measured by reversed-phase HPLC. The dissolved sample is separated into peaks, a detector records the area under each peak, and the main peptide peak is expressed as a percentage of the total peak area. A report of 98% purity by HPLC means the target peptide accounts for about 98% of the detected peak area, with the remaining 2% being related impurities.

What does reversed-phase HPLC mean?

Reversed-phase HPLC uses a non-polar, water-hating stationary phase — usually silica particles coated with C18 or C8 hydrocarbon chains — and a water-based mobile phase. Peptides stick to the surface by how hydrophobic they are and are washed off as the proportion of organic solvent rises. It is the dominant mode for peptide analysis because it separates closely related molecules well.

Why are peptides detected at 214 nm in HPLC?

The peptide bond itself — the amide link between residues — absorbs ultraviolet light strongly in the far-UV region around 190 to 220 nm. Detecting near 214 nm therefore sees every peptide bond, so it registers essentially any peptide regardless of its sequence. Detection at 280 nm instead sees only the aromatic side chains of tryptophan, tyrosine and phenylalanine, so it is more selective but misses peptides without those residues.

What is a good HPLC purity for a research peptide?

Purity is reported as a percentage of total peak area, and common grades are crude, desalted, and HPLC-purified to greater than 95% or greater than 98%. A higher number means less related impurity, but the figure only describes composition — it is not a measure of how much peptide is in the vial, and it says nothing about safety or effect. What counts as adequate depends on the research use, not on a universal threshold.

What is the difference between HPLC and mass spectrometry for peptides?

HPLC answers how pure a sample is: it separates the components and reports the main peptide as a percentage of total peak area. Mass spectrometry answers what the molecule is: it weighs the peptide and matches the mass to the intended sequence. Purity without identity, or identity without purity, is only half the picture, which is why a certificate of analysis normally carries both.

What is retention time in HPLC?

Retention time is how long a component takes to travel through the column and reach the detector under a given set of conditions. It is characteristic of a molecule for that method, so a peak appearing at the expected retention time is one piece of evidence for a component’s identity, though retention time alone does not prove it. It is read off the horizontal axis of the chromatogram.

Does a high HPLC purity mean a peptide is safe or effective?

No. An HPLC purity figure is an analytical measurement of composition — the fraction of detected material that is the target peptide. It describes the molecule, not any effect of the molecule, and makes no statement about safety, biological activity or fitness for any use in a person or an animal. Research peptides are laboratory materials, and a purity number is a quality metric, not a health claim.

References

1. Ettre, L. S. (1993). Nomenclature for chromatography (IUPAC Recommendations 1993). Pure and Applied Chemistry, 65(4), 819–872. https://rsync.iupac.org/publications/pac/1993/pdf/6504x0819.pdf
2. Martin, A. J. P., & Synge, R. L. M. (1941). A new form of chromatogram employing two liquid phases. Biochemical Journal, 35(12), 1358–1368.
3. The Nobel Prize in Chemistry 1952 — Archer J. P. Martin and Richard L. M. Synge “for their invention of partition chromatography.” NobelPrize.org. https://www.nobelprize.org/prizes/chemistry/1952/
4. van Deemter, J. J., Zuiderweg, F. J., & Klinkenberg, A. (1956). Longitudinal diffusion and resistance to mass transfer as causes of non-ideality in chromatography. Chemical Engineering Science, 5(6), 271–289. doi:10.1016/0009-2509(56)80003-1
5. Horváth, Cs., Preiss, B. A., & Lipsky, S. R. (1967). Fast liquid chromatography: an investigation of operating parameters and the separation of nucleotides on pellicular ion exchangers. Analytical Chemistry, 39(12), 1422–1428.
6. Ettre, L. S. (2005). Csaba Horváth and the development of the first modern high-performance liquid chromatograph. LCGC North America, 23(5), 486–495.
7. Grace Vydac (2002). The Handbook of Analysis and Purification of Peptides and Proteins by Reversed-Phase HPLC (3rd ed.). https://wolfson.huji.ac.il/purification/PDF/ReversePhase/VYDAChandbookRPC.pdf
8. High-performance liquid chromatography. Wikipedia. https://en.wikipedia.org/wiki/High-performance_liquid_chromatography
9. Van Deemter equation. Wikipedia. https://en.wikipedia.org/wiki/Van_Deemter_equation
10. Csaba Horváth (chemical engineer). Wikipedia. https://en.wikipedia.org/wiki/Csaba_Horv%C3%A1th_(chemical_engineer)
11. United States Pharmacopeia. General Chapter <621> Chromatography. USP–NF. https://www.usp.org/
12. Waters Corporation (2004). Waters introduces ACQUITY UltraPerformance LC (UPLC), the first commercial system using sub-2-µm particles. Outsourcing-Pharma. https://www.outsourcing-pharma.com/Article/2004/03/09/Waters-improves-analytical-technology-with-new-product
13. Aguilar, M.-I. (Ed.) (2004). HPLC of Peptides and Proteins: Methods and Protocols. Methods in Molecular Biology, vol. 251. Humana Press.
14. Snyder, L. R., Kirkland, J. J., & Dolan, J. W. (2010). Introduction to Modern Liquid Chromatography (3rd ed.). Wiley.
15. Mant, C. T., & Hodges, R. S. (Eds.) (1991). High-Performance Liquid Chromatography of Peptides and Proteins: Separation, Analysis, and Conformation. CRC Press.
16. Kuipers, B. J. H., & Gruppen, H. (2007). Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm. Journal of Agricultural and Food Chemistry, 55(14), 5445–5451.

For the analysis that confirms what the molecule is, see What Is Mass Spectrometry; for what a purity percentage does and does not mean, Peptide Purity Grades Explained and What Is Net Peptide Content; for how purity, identity and content sit on one document, Understanding Peptide COA Testing; and for why the counterion is not part of the peptide, TFA vs Acetate in Peptides.

All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption. This guide is educational and explains an analytical technique in general terms; it is not medical advice, does not describe how to use any product, and makes no claim about the properties or effects of any specific compound.